Literature DB >> 11454541

High, intermittent dose of all-trans retinoic acid in combination with alpha-interferon for advanced multiple myeloma.

J Juturi, R A Bukowski, K Bocock, T Bloom, J Finke, M A Hussein.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11454541

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  3 in total

1.  Novel therapy in multiple myeloma.

Authors:  Agustin Avilés; Natividad Neri; M Jesús Nambo; Sergio Cleto; Claudia Castañeda; Martha González; Alejandra Talavera; Judith Huerta-Guzmán
Journal:  Invest New Drugs       Date:  2005-10       Impact factor: 3.850

2.  G1P3, an IFN-induced survival factor, antagonizes TRAIL-induced apoptosis in human myeloma cells.

Authors:  Venugopalan Cheriyath; Keith B Glaser; Jeffrey F Waring; Rachid Baz; Mohamad A Hussein; Ernest C Borden
Journal:  J Clin Invest       Date:  2007-10       Impact factor: 14.808

Review 3.  Role of Apo2L/TRAIL and Bcl-2-family proteins in apoptosis of multiple myeloma.

Authors:  Quan Chen; Subrata Ray; Mohamad A Hussein; Gordan Srkalovic; Alexandru Almasan
Journal:  Leuk Lymphoma       Date:  2003-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.